TERC and dyskeratosis congenita: TA is also required for the maintenance of normal stem cells, and in patients with dyskeratosis congenita (DKC) inactivating mutations in TERT and TERC may lead to the loss of normal hematopoietic stem cells and aplastic anemia [25].